EUVIMEDDécouvrir EUVIMED
Crossref

Advances in Targeted Immunotherapies for Cancer Treatment

Dr. Rami Al-Farouq

American Journal Of Pharmacy And Pharmacology · 2023-12-31 · 4 (6) · 9-12

DOI: 10.71465/ajpp.2829 ↗

At a glance

Journal article in American Journal Of Pharmacy And Pharmacology, published online on 2023-12-31. Written by Dr. Rami Al-Farouq.

RésuméRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Targeted immunotherapies represent a major breakthrough in cancer treatment, offering precise and personalized approaches to combating malignancies. These therapies enhance the body’s immune system to recognize and eliminate cancer cells with minimal damage to normal tissues. Recent advances include immune checkpoint inhibitors, CAR-T cell therapies, bispecific antibodies, and cancer vaccines. This article explores the mechanisms, clinical applications, challenges, and future directions of targeted immunotherapies in oncology.

Cite

APA

Al-Farouq, D. R. (2023). Advances in Targeted Immunotherapies for Cancer Treatment. American Journal Of Pharmacy And Pharmacology, 4(6), 9-12. https://doi.org/10.71465/ajpp.2829

Vancouver

Al-Farouq DR. Advances in Targeted Immunotherapies for Cancer Treatment. American Journal Of Pharmacy And Pharmacology. 2023;4(6):9-12. doi:10.71465/ajpp.2829

BibTeX
@article{AlFarouq2023,
  author = {Al-Farouq, Dr. Rami},
  title = {Advances in Targeted Immunotherapies for Cancer Treatment},
  journal = {American Journal Of Pharmacy And Pharmacology},
  year = {2023},
  volume = {4},
  number = {6},
  pages = {9--12},
  doi = {10.71465/ajpp.2829}
}
Start for free →